Kapoor, S.; Gustafson, T.; Zhang, M.; Chen, Y.-S.; Li, J.; Nguyen, N.; Perez, J.E.T.; Dashwood, W.M.; Rajendran, P.; Dashwood, R.H.
Deacetylase Plus Bromodomain Inhibition Downregulates ERCC2 and Suppresses the Growth of Metastatic Colon Cancer Cells. Cancers 2021, 13, 1438.
https://doi.org/10.3390/cancers13061438
AMA Style
Kapoor S, Gustafson T, Zhang M, Chen Y-S, Li J, Nguyen N, Perez JET, Dashwood WM, Rajendran P, Dashwood RH.
Deacetylase Plus Bromodomain Inhibition Downregulates ERCC2 and Suppresses the Growth of Metastatic Colon Cancer Cells. Cancers. 2021; 13(6):1438.
https://doi.org/10.3390/cancers13061438
Chicago/Turabian Style
Kapoor, Sabeeta, Trace Gustafson, Mutian Zhang, Ying-Shiuan Chen, Jia Li, Nhung Nguyen, Jorge Enrique Tovar Perez, Wan Mohaiza Dashwood, Praveen Rajendran, and Roderick H. Dashwood.
2021. "Deacetylase Plus Bromodomain Inhibition Downregulates ERCC2 and Suppresses the Growth of Metastatic Colon Cancer Cells" Cancers 13, no. 6: 1438.
https://doi.org/10.3390/cancers13061438
APA Style
Kapoor, S., Gustafson, T., Zhang, M., Chen, Y.-S., Li, J., Nguyen, N., Perez, J. E. T., Dashwood, W. M., Rajendran, P., & Dashwood, R. H.
(2021). Deacetylase Plus Bromodomain Inhibition Downregulates ERCC2 and Suppresses the Growth of Metastatic Colon Cancer Cells. Cancers, 13(6), 1438.
https://doi.org/10.3390/cancers13061438